London Daily

Focus on the big picture.
Tuesday, Aug 05, 2025

Oxford Covid vaccine 'safe and effective' study shows

Oxford Covid vaccine 'safe and effective' study shows

The Oxford/AstraZeneca Covid vaccine is safe and effective, giving good protection, researchers have confirmed in The Lancet journal.

Most in the study were younger than 55, but the results so far indicate it does work well in older people too.

The data also suggest it can reduce spread of Covid, as well as protect against illness and death.

The paper, assessed by independent scientists, sets out full results from advanced trials of over 20,000 people.

Regulators, who will have seen the same data, are considering the jab for emergency use.

But there are still important questions about what dose to give, as well as who it will protect.

When the interim trial results were made public in a press release about a fortnight ago, the researchers reported three efficacy levels for the vaccine - an overall effectiveness of 70%, a lower one of 62% and a high of 90%.

That's because different doses of the vaccine were used in one part of the trial. Some volunteers were given shots that were half the strength than originally planned.
Yet that "wrong" dose turned out to be a winner - giving 90% protection - while two standard doses gave 62%.

The Lancet report reveals 1,367 people - out of many thousands in the trial - received the half dose followed by a full dose, which gave them 90% protection against getting ill with Covid-19.

The relatively small numbers means it is hard to draw firm conclusions.

None of that group were over the age of 55 though - and experts know it is older people who are most at risk of severe Covid illness.

In terms of safety, there was one severe adverse event potentially related to the vaccine and another one - a high temperature - that is still being investigated.

Both these participants are recovering and are still in the trial.

The study also measured protection against asymptomatic infection by asking volunteers to do regular swabs to check if they had Covid without feeling unwell.

More of these cases were seen in the group that did not receive the vaccine.

Pascal Soriot, chief executive officer for AstraZeneca said: "The results show that the vaccine is effective against Covid-19, with in particular no severe infections and no hospitalisations in the vaccine group, as well as safe and well tolerated.

"We have begun submitting data to regulatory authorities around the world for early approval and our global supply chains are up and running, ready to quickly begin delivering hundreds of millions of doses on a global scale at no profit."

Dr Charlie Weller, Head of Vaccines at Wellcome, said: "Today marks another key milestone in the Covid-19 vaccine journey.

"Although we await the trial completion and full data, it is highly encouraging to see the data behind the interim results announced last month, including an analysis of the different dosing regimens. This suggests that this vaccine could prevent asymptomatic disease."

AstraZeneca executive vice-president Sir Mene Pangalos said adults of all ages needed to be vaccinated to make a "dent" in the pandemic.

"I realise the people that are most severely impacted by disease are the over-65s, over-75s, over-85s, but the reality is we need to actually have vaccines that immunise everyone from adolescence to the oldest adults to really dent the pandemic around the world," he said.

Meanwhile, the UK has started a mass vaccination campaign with another Covid jab made by Pfizer/BioNTech.

On Tuesday Margaret Keenan, a 91-year-old grandmother, became the first person in the world to get the Pfizer Covid-19 jab as part of a mass vaccination programme..

The Oxford/AstraZeneca vaccine could also play a major role in fighting the pandemic if it is approved soon.

It is cheaper than some of the other Covid vaccines and easier to store and distribute.



The UK government has pre-ordered 100 million doses of the Oxford vaccine, which uses a harmless virus altered to look a lot more like the virus that causes Covid-19.

AstraZeneca says it will make three billion doses for the world next year.


Laura Foster explains why the Oxford vaccine matters


Newsletter

Related Articles

0:00
0:00
Close
Elon Musk Receives $23.7 Billion Tesla Stock Award
Texas House Paralyzed After Democrats Walk Out Over Redistricting
Mexican Cartels Complicate Sheinbaum’s U.S. Security Talks
Mark Zuckerberg Declares War on the iPhone
India Rejects U.S. Tariff Threat, Defends Russian Oil Purchases
United States Establishes Strategic Bitcoin Reserve and Digital Asset Stockpile
Thousands of Private ChatGPT Conversations Accidentally Indexed by Google
China Tightens Mineral Controls, Curtailing Critical Inputs for Western Defence Contractors
OpenAI’s Bold Bet: Teaching AI to Think, Not Just Chat
Tesla Seeks Shareholder Approval for $29 Billion Compensation Package for Elon Musk
Nvidia is cutting prices on its RTX 50-series graphics cards after sales slowed and inventories piled up
Ghislaine Maxwell Transferred to Minimum-Security Prison Amid Ongoing DOJ Discussions
U.S. Tariffs Surge to Highest Levels in Nearly a Century Under Second Trump Term
Matt Taibbi Slams Media for Role in Russiagate Narrative
Pilots Call for Mental Health Support Without Stigma
All Five Trapped Miners Found Dead After El Teniente Mine Collapse
Ong Beng Seng Pleads Guilty in Corruption Case Linked to Former Singapore Transport Minister
BP’s Largest Oil and Gas Find in 25 Years Uncovered Offshore Brazil
Italy Fines Shein One Million Euros for Misleading Sustainability Claims
JPMorgan and Coinbase Unveil Partnership to Let Chase Cardholders Buy Crypto Directly
Declassified Annex Links Soros‑Affiliated Officials and Clinton Campaign to ‘Russiagate’ Narrative
UK's Online Safety Law: A Front for Censorship
Nationwide Protests Erupt in Brazil Demanding Presidential Resignation
Parents Abandon Child at Barcelona Airport Over Passport Issue
Mystery Surrounds Death of Brazilian Woman with iPhones Glued to Her Body
Bus Driver Discovers Toddler Hidden in Suitcase in New Zealand
Switzerland Celebrates 734 Years of Independence Amid Global Changes
U.S. Opens Official Investigation into Former Trump Prosecutor Jack Smith
Leaked audio of Canada's new PM Mark Carney admitting the truth about the Net Zero agenda: "We're gonna make a lot of money off of this."
China Enforces Comprehensive Ban on Cryptocurrency Activities
Absolutely 100% Realistic EVO Series Doll by EXDOLL (Chinese Company) used mainly for carnal purposes
World Economic Forum founder Klaus Schwab: "In this new world, we must accept... total transparency. You have to get used to it. You have to behave accordingly. But if you have nothing to hide, you shouldn't be afraid."
Meet Mufti Hamid Patel, head of Office for Standards in Education in Pakistan
George Soros tells the World Economic Forum: "President Trump is a con man and the ultimate narcissist, who wants the world to revolve around him."
Hamas are STARVING the hostages.
Decline in Tourism in Majorca Amidst Ongoing Anti-Tourism Protests
British Tourist Dies Following Hair Transplant in Turkey, Police Investigate
Poland Begins Excavation at Dziemiany After New Clue to World War II‑Era Nazi Treasure
WhatsApp Users Targeted in New Scam Involving Account Takeovers
Trump Threatens Canada with Tariffs Over Palestinian State Recognition
Trump Deploys Nuclear Submarines After Threats from Former Russian President Medvedev
Trump Sues Murdoch in “Heavyweight Bout”: Lawsuit Over Alleged Epstein Letter Sets Stage for Courtroom Showdown
Germany Enters Fiscal Crisis as Cabinet Approves €174 Billion in New Debt
Trump Administration Finalizes Broad Tariff Increases on Global Trade Partners
J.K. Rowling Limits Public Engagements Citing Safety Fears
JD.com Launches €2.2 Billion Bid for German Electronics Retailer Ceconomy
Azerbaijan Proceeds with Plan to Legalise Casinos on Artificial Islands
Former Judge Charged After Drunk Driving Crash Kills Comedian in Brazil
Jeff Bezos hasn’t paid a dollar in taxes for decades. He makes billions and pays $0 in taxes, LEGALLY
China Increases Use of Exit Bans Amid Rising U.S. Tensions
×